SCHEMBL4348191

SCHEMBL4348191

COc1c(C(=O)O)ccc2c1c(-c1cc3ccccc3o1)nn2C(CC(N)=O)N1CCCC1=O

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.35
ALDH1A1 P00352 5/20 0.35
TDP1 Q9NUW8 1/20 0.35
KMT2A Q03164 7/20 0.34
MEN1 O00255 6/20 0.34
MAPT P10636 3/20 0.34
HTT P42858 2/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
POLB P06746 3/20 0.34
L3MBTL1 Q9Y468 3/20 0.33
JAK2 O60674 1/20 0.33
JAK3 P52333 1/20 0.33
GAA P10253 2/20 0.32
PLAU P00749 2/20 0.32
F11 P03951 1/20 0.32
KLKB1 P03952 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4335958 0.86 PIK3CD (0.34) KDM4EALDH1A1MAPTCYP1A2CYP2C9
SCHEMBL4332589 0.84 ACLY (0.33) JAK2JAK3PLAUSIRT2SIRT1
SCHEMBL4335961 0.81 CSNK1E (0.33) KDM4EALDH1A1HTT
SCHEMBL4334570 0.78 KDM4E (0.39) KDM4EALDH1A1TDP1KMT2AMEN1
SCHEMBL4341551 0.74 ALDH1A1 (0.37) KDM4EALDH1A1TDP1KMT2AMEN1
SCHEMBL4331228 0.73 KDM4E (0.36) KDM4EALDH1A1TDP1KMT2AMEN1
SCHEMBL4341005 0.71 CSNK1E (0.34)
SCHEMBL2866727 0.67 JAK2 (0.42) KDM4EALDH1A1TDP1KMT2AMEN1
SCHEMBL4333973 0.67 PLAU (0.33) PLAUSIRT2SIRT1
SCHEMBL2872405 0.65 MAPT (0.41) KDM4EALDH1A1TDP1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7541376-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-02 US disclosed
US-20050282880-A1 Novel 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-12-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050282880-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 KDM4E 2531/4885ALDH1A1 1588/4885TDP1 3905/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.